Misplaced Pages

AM-1248: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 02:14, 21 September 2011 editCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (changes to watched fields - updated 'ChemSpiderID_Ref', 'UNII_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report [[Misplaced Pages talk:Wik← Previous edit Revision as of 07:34, 10 October 2011 edit undoMeodipt (talk | contribs)Autopatrolled, Extended confirmed users, Pending changes reviewers, Rollbackers35,718 editsNo edit summaryNext edit →
Line 39: Line 39:
}} }}


'''AM-1248''' is a drug which acts as a moderately potent ] for both the ]s ] and ], but with some dispute between sources over its exact potency and selectivity.<!-- although note Ki values often cannot be compared directly between literature sources if the assay conditions are different --> Replacing the 3-(1-naphthoyl) group found in many indole derived cannabinoid ligands, with an ]] group, generally confers significant CB<sub>2</sub> selectivity,<ref>{{Cite doi|10.1021/jm901214q}}</ref> but reasonable CB<sub>1</sub> affinity and selectivity is retained when an N-methylpiperidin-2-ylmethyl substitution is used at the indole 1-position.<ref name="US 7820144">{{Ref patent2 | country = US | number = 7820144 | status = granted | title = Receptor selective cannabimimetic aminoalkylindoles | pubdate = 2007-01-05 | gdate = 2010-10-26 | pridate= | inventor = Makriyannis A, Deng H | assign1= }}</ref><ref name="WO 2001 28557 A1">{{Ref patent2 | country = WO | number = 200128557 | status = granted | title = Cannabimimetic indole derivatives | pubdate = 2001-04-26 | gdate = 2001-06-07 | pridate= 1999-10-18 | inventor = Makriyannis A, Deng H | assign1= }}</ref> The related compound 1-pentyl-3-(1-adamantoyl)indole was identified as having been sold as a ] ] in Hungary in 2011, along with another synthetic cannabinoid ].<ref name="pmid21813254">{{cite journal |author=Jankovics P, Váradi A, Tölgyesi L, Lohner S, Németh-Palotás J, Balla J |title=Detection and identification of the new potential synthetic cannabinoids 1-pentyl-3-(2-iodobenzoyl)indole and 1-pentyl-3-(1-adamantoyl)indole in seized bulk powders in Hungary |journal=Forensic Science International |volume= |issue= |pages= |year=2011 |month=August |pmid=21813254 |doi=10.1016/j.forsciint.2011.07.011 |url=}}</ref> '''AM-1248''' is a drug which acts as a moderately potent ] for both the ]s ] and ], but with some dispute between sources over its exact potency and selectivity.<!-- although note Ki values often cannot be compared directly between literature sources if the assay conditions are different --> Replacing the 3-(1-naphthoyl) group found in many indole derived cannabinoid ligands, with an ]] group, generally confers significant CB<sub>2</sub> selectivity,<ref>{{Cite doi|10.1021/jm901214q}}</ref> but reasonable CB<sub>1</sub> affinity and selectivity is retained when an N-methylpiperidin-2-ylmethyl substitution is used at the indole 1-position.<ref name="US 7820144">{{Ref patent2 | country = US | number = 7820144 | status = granted | title = Receptor selective cannabimimetic aminoalkylindoles | pubdate = 2007-01-05 | gdate = 2010-10-26 | pridate= | inventor = Makriyannis A, Deng H | assign1= }}</ref><ref name="WO 2001 28557 A1">{{Ref patent2 | country = WO | number = 200128557 | status = granted | title = Cannabimimetic indole derivatives | pubdate = 2001-04-26 | gdate = 2001-06-07 | pridate= 1999-10-18 | inventor = Makriyannis A, Deng H | assign1= }}</ref> The related compound ] was identified as having been sold as a ] ] in Hungary in 2011, along with another synthetic cannabinoid ].<ref name="pmid21813254">{{cite journal |author=Jankovics P, Váradi A, Tölgyesi L, Lohner S, Németh-Palotás J, Balla J |title=Detection and identification of the new potential synthetic cannabinoids 1-pentyl-3-(2-iodobenzoyl)indole and 1-pentyl-3-(1-adamantoyl)indole in seized bulk powders in Hungary |journal=Forensic Science International |volume= |issue= |pages= |year=2011 |month=August |pmid=21813254 |doi=10.1016/j.forsciint.2011.07.011 |url=}}</ref>


==See also== ==See also==

Revision as of 07:34, 10 October 2011

Pharmaceutical compound
AM-1248
Identifiers
IUPAC name
  • 1--3-(adamant-1-oyl)indole
PubChem CID
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC26H34N2O
Molar mass390.561 g/mol g·mol
3D model (JSmol)
SMILES
  • CN1CCCCC1Cn(c6)c2ccccc2c6C(=O)C5(C3)CC(CC3C4)CC4C5
  (verify)

AM-1248 is a drug which acts as a moderately potent agonist for both the cannabinoid receptors CB1 and CB2, but with some dispute between sources over its exact potency and selectivity. Replacing the 3-(1-naphthoyl) group found in many indole derived cannabinoid ligands, with an adamantoyl group, generally confers significant CB2 selectivity, but reasonable CB1 affinity and selectivity is retained when an N-methylpiperidin-2-ylmethyl substitution is used at the indole 1-position. The related compound 1-pentyl-3-(1-adamantoyl)indole was identified as having been sold as a cannabinoid designer drug in Hungary in 2011, along with another synthetic cannabinoid AM-679.

See also

References

  1. Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1021/jm901214q, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with |doi=10.1021/jm901214q instead.
  2. US patent 7820144, Makriyannis A, Deng H, "Receptor selective cannabimimetic aminoalkylindoles", granted 2010-10-26 
  3. WO patent 200128557, Makriyannis A, Deng H, "Cannabimimetic indole derivatives", granted 2001-06-07 
  4. Jankovics P, Váradi A, Tölgyesi L, Lohner S, Németh-Palotás J, Balla J (2011). "Detection and identification of the new potential synthetic cannabinoids 1-pentyl-3-(2-iodobenzoyl)indole and 1-pentyl-3-(1-adamantoyl)indole in seized bulk powders in Hungary". Forensic Science International. doi:10.1016/j.forsciint.2011.07.011. PMID 21813254. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
Cannabinoids
Phytocannabinoids
(comparison)
Cannabibutols
Cannabichromenes
Cannabicyclols
Cannabidiols
Cannabielsoins
Cannabigerols
Cannabiphorols
Cannabinols
Cannabitriols
Cannabivarins
Delta-8-tetrahydrocannabinols
Delta-9-tetrahydrocannabinols
Delta-10-Tetrahydrocannabinols
Miscellaneous cannabinoids
Active metabolites
Endocannabinoids
Synthetic
cannabinoid
receptor
agonists /
neocannabinoids
Classical cannabinoids
(dibenzopyrans)
Non-classical
cannabinoids
Adamantoylindoles
Benzimidazoles
Benzoylindoles
Cyclohexylphenols
Eicosanoids
Indazole-3-
carboxamides
Indole-3-carboxamides
Indole-3-carboxylates
Naphthoylindazoles
Naphthoylindoles
Naphthoylpyrroles
Naphthylmethylindenes
Naphthylmethylindoles
Phenylacetylindoles
Pyrazolecarboxamides
Tetramethylcyclo-
propanoylindazoles
Tetramethylcyclo-
propanoylindoles
Others
Allosteric CBRTooltip Cannabinoid receptor ligands
Endocannabinoid
enhancers

(inactivation inhibitors)
Anticannabinoids
(antagonists/inverse
agonists/antibodies)
Stub icon

This cannabinoid related article is a stub. You can help Misplaced Pages by expanding it.

Categories: